Sofía Perea - Concepedia

Author

Sofía Perea

The University of Texas Health Science Center at San Antonio ORCID

Also Known As

S PEREA, S Perea, S. Perea, Silvia Perea, Sofia Hidalgo Perea, Sofia Perea, Sofía Hidalgo Perea, Sofía Perea

153

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio South Texas Veterans Health Care System Murphy Oil Corporation (United States)Hospital for Special Surgery Spanish National Cancer Research Centre

About

Sofía Perea is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, immunology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.1K
2	Health Sciences	4	4	481
3	Engineering	2	2	70
4	Cell Biology	2	2	70
5	Biomedical Engineering	1	1	23

Sofía Perea

Publications

Citations

H-Index

Page 1

	Year	Citations
Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in <i>Candida albicans</i> Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients Sofía Perea, José L. López-Ribot, William R. Kirkpatrick, Antimicrobial Agents and Chemotherapy	2001	466
Antifungal Resistance in Pathogenic Fungi Sofía Perea, Thomas F. Patterson Clinical Infectious Diseases Intrinsic ResistanceAntifungal AgentHealth SciencesAntifungal AgentsAntifungal Resistance	2002	291
Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis William R. Kirkpatrick, Sofía Perea, Brent J. Coco, Antimicrobial Agents and Chemotherapy Invasive AspergillosisCaspofungin AloneAntifungal AgentGuinea PigsAntifungal Agents	2002	283
An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors María L. Amador, Darin Oppenheimer, Sofía Perea, Cancer Research	2004	242
Prevalence and Risk Factors of Tinea Unguium and Tinea Pedis in the General Population in Spain Sofía Perea, María José Ramos, Margarita Garau, Journal of Clinical Microbiology Tinea UnguiumTinea PedisPathologyClinical DermatologyContact Dermatitis	2000	197
In Vitro Interaction of Caspofungin Acetate with Voriconazole against Clinical Isolates of <i>Aspergillus</i> spp Sofía Perea, Gloria M. González, Annette W. Fothergill, Antimicrobial Agents and Chemotherapy	2002	187
Multiple Resistant Phenotypes of <i>Candida albicans</i> Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients José L. López-Ribot, Robert K. McAtee, Sofía Perea, Antimicrobial Agents and Chemotherapy ImmunologyClinical MycologyFluconazole ResistanceMultiple Resistant PhenotypesDrug Resistance	1999	95
Comparison of High-Performance Liquid Chromatographic and Microbiological Methods for Determination of Voriconazole Levels in Plasma Sofía Perea, Gennethel Pennick, Asha Modak, Antimicrobial Agents and Chemotherapy	2000	94
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models Myriam Fabre, Cristina Suárez Ferrer, Saioa Domínguez-Hormaetxe, Clinical Cancer Research	2020	92
Comparison of In Vitro Activities of Voriconazole and Five Established Antifungal Agents against Different Species of Dermatophytes Using a Broth Macrodilution Method Sofía Perea, Annette W. Fothergill, Deanna A. Sutton, Journal of Clinical Microbiology	2001	90

Page 1